Ibrance 100 mg

IBRANCE 100 MG is a medication used in cancer treatment. This oral tablet, manufactured by Pfizer Canada ULC, contains palbociclib, a CDK4/6 inhibitor. Learn more about its uses and effects.

IBRANCE 100 MG is primarily used in combination with other treatments for certain types of cancer. It is often prescribed for advanced or metastatic breast cancer in postmenopausal women. The medication works by inhibiting specific proteins that promote cancer cell growth. Patients should consult their healthcare provider to understand what is IBRANCE 100 MG used for in their specific case.

Common effects of IBRANCE 100 MG may include fatigue, nausea, and low blood cell counts. Some users might experience hair loss or infections. These effects can vary widely among individuals. It is important to discuss any persistent or severe symptoms with a healthcare professional.

IBRANCE 100 MG should be handled with care. It is essential to follow the prescribed dosage and administration instructions. Pregnant women or those planning to become pregnant should avoid this medication due to potential risks. Always store the tablets in a cool, dry place away from children.

IBRANCE 100 MG may interact with certain medications, including strong CYP3A inhibitors and inducers. It is crucial to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances may also affect the medication's efficacy.